Applied Immune Sciences Inc., Rhône-Poulenc Rorer Inc. deal

Duke University Medical Center and ExVivo Therapies, a joint venture between AISX and RPR, will construct and operate a 20,000 square foot cell-processing center in Durham, N.C., for growing and enhan...